Loading…

Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases

According to investigations in phytomedicine and ethnopharmacology, the therapeutic properties of garlic (Allium sativum) have been described by ancestral cultures. Notwithstanding, it is of particular concern to elucidate the molecular mechanisms underlying this millenary empirical knowledge. Allic...

Full description

Saved in:
Bibliographic Details
Published in:Life sciences (1973) 2020-05, Vol.249, p.117513-117513, Article 117513
Main Authors: Mocayar Marón, Feres José, Camargo, Alejandra Beatriz, Manucha, Walter
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c353t-c02feec4536e254fb150137507c1fbfdd66e30945ef7093afc218cb386e8384c3
cites cdi_FETCH-LOGICAL-c353t-c02feec4536e254fb150137507c1fbfdd66e30945ef7093afc218cb386e8384c3
container_end_page 117513
container_issue
container_start_page 117513
container_title Life sciences (1973)
container_volume 249
creator Mocayar Marón, Feres José
Camargo, Alejandra Beatriz
Manucha, Walter
description According to investigations in phytomedicine and ethnopharmacology, the therapeutic properties of garlic (Allium sativum) have been described by ancestral cultures. Notwithstanding, it is of particular concern to elucidate the molecular mechanisms underlying this millenary empirical knowledge. Allicin (S-allyl prop-2-ene-1-sulfinothioate), a thioester of sulfenic acid, is one of the main bioactive compounds present in garlic, and it is responsible for the particular aroma of the spice. The pharmacological attributes of allicin integrate a broad spectrum of properties (e.g., anti-inflammatory, immunomodulatory, antibiotic, antifungal, antiparasitic, antioxidant, nephroprotective, neuroprotective, cardioprotective, and anti-tumoral activities, among others). The primary goal of the present article is to review and clarify the common molecular mechanisms by which allicin and its derivates molecules may perform its therapeutic effects on cardiovascular diseases and neuroinflammatory processes. The intricate interface connecting the cardiovascular and nervous systems suggests that the impairment of one organ could contribute to the dysfunction of the other. Allicin might target the cornerstone of the pathological processes underlying cardiovascular and neuroinflammatory disorders, like inflammation, renin-angiotensin-aldosterone system (RAAS) hyperactivation, oxidative stress, and mitochondrial dysfunction. Indeed, the current evidence suggests that allicin improves mitochondrial function by enhancing the expression of HSP70 and NRF2, decreasing RAAS activation, and promoting mitochondrial fusion processes. Finally, allicin represents an attractive therapeutic alternative targeting the complex interaction between cardiovascular and neuroinflammatory disorders. [Display omitted]
doi_str_mv 10.1016/j.lfs.2020.117513
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2374341178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320520302617</els_id><sourcerecordid>2374341178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-c02feec4536e254fb150137507c1fbfdd66e30945ef7093afc218cb386e8384c3</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi1ERZfCD-CCcuSSZWzHSRZO1YoCUiUu5Wx5J-OtV_5Y7KRS_z2uUnrkNBrpeV_NPIx94LDlwPvPp623ZStA1J0PistXbMPHYddCL_lrtgEQXSsFqEv2tpQTACg1yDfsUgreKQnDhh2vvXfoYnO-NzkYTD4dH780-xRCik1InnDxJjeB8N5EV0JpzNG4WOYm0pKTi9abEMzsKm7i1KDJk0sPpqy5yRUyhco7dmGNL_T-eV6x3zff7vY_2ttf33_ur29blErOLYKwRFiP60mozh64Ai4HBQNye7DT1PckYdcpsgPspLEo-IgHOfY0yrFDecU-rb3nnP4sVGYdXEHy3kRKS9FCDp3sqq2xonxFMadSMll9zi6Y_Kg56Ce_-qSrX_3kV69-a-bjc_1yCDS9JP4JrcDXFaD65IOjrAs6ikiTy4SznpL7T_1fnRaM_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2374341178</pqid></control><display><type>article</type><title>Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases</title><source>ScienceDirect Freedom Collection</source><creator>Mocayar Marón, Feres José ; Camargo, Alejandra Beatriz ; Manucha, Walter</creator><creatorcontrib>Mocayar Marón, Feres José ; Camargo, Alejandra Beatriz ; Manucha, Walter</creatorcontrib><description>According to investigations in phytomedicine and ethnopharmacology, the therapeutic properties of garlic (Allium sativum) have been described by ancestral cultures. Notwithstanding, it is of particular concern to elucidate the molecular mechanisms underlying this millenary empirical knowledge. Allicin (S-allyl prop-2-ene-1-sulfinothioate), a thioester of sulfenic acid, is one of the main bioactive compounds present in garlic, and it is responsible for the particular aroma of the spice. The pharmacological attributes of allicin integrate a broad spectrum of properties (e.g., anti-inflammatory, immunomodulatory, antibiotic, antifungal, antiparasitic, antioxidant, nephroprotective, neuroprotective, cardioprotective, and anti-tumoral activities, among others). The primary goal of the present article is to review and clarify the common molecular mechanisms by which allicin and its derivates molecules may perform its therapeutic effects on cardiovascular diseases and neuroinflammatory processes. The intricate interface connecting the cardiovascular and nervous systems suggests that the impairment of one organ could contribute to the dysfunction of the other. Allicin might target the cornerstone of the pathological processes underlying cardiovascular and neuroinflammatory disorders, like inflammation, renin-angiotensin-aldosterone system (RAAS) hyperactivation, oxidative stress, and mitochondrial dysfunction. Indeed, the current evidence suggests that allicin improves mitochondrial function by enhancing the expression of HSP70 and NRF2, decreasing RAAS activation, and promoting mitochondrial fusion processes. Finally, allicin represents an attractive therapeutic alternative targeting the complex interaction between cardiovascular and neuroinflammatory disorders. [Display omitted]</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2020.117513</identifier><identifier>PMID: 32145307</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Allicin ; Anti-Inflammatory Agents - therapeutic use ; Cardiotonic Agents - therapeutic use ; Cardiovascular Diseases - drug therapy ; Cardiovascular disorders ; Garlic ; Humans ; Inflammation - drug therapy ; Mitochondria ; Nervous System Diseases - drug therapy ; Neuroprotection ; Neuroprotective Agents - therapeutic use ; Organosulfur compounds ; Oxidative stress ; Sulfinic Acids - therapeutic use</subject><ispartof>Life sciences (1973), 2020-05, Vol.249, p.117513-117513, Article 117513</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-c02feec4536e254fb150137507c1fbfdd66e30945ef7093afc218cb386e8384c3</citedby><cites>FETCH-LOGICAL-c353t-c02feec4536e254fb150137507c1fbfdd66e30945ef7093afc218cb386e8384c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32145307$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mocayar Marón, Feres José</creatorcontrib><creatorcontrib>Camargo, Alejandra Beatriz</creatorcontrib><creatorcontrib>Manucha, Walter</creatorcontrib><title>Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>According to investigations in phytomedicine and ethnopharmacology, the therapeutic properties of garlic (Allium sativum) have been described by ancestral cultures. Notwithstanding, it is of particular concern to elucidate the molecular mechanisms underlying this millenary empirical knowledge. Allicin (S-allyl prop-2-ene-1-sulfinothioate), a thioester of sulfenic acid, is one of the main bioactive compounds present in garlic, and it is responsible for the particular aroma of the spice. The pharmacological attributes of allicin integrate a broad spectrum of properties (e.g., anti-inflammatory, immunomodulatory, antibiotic, antifungal, antiparasitic, antioxidant, nephroprotective, neuroprotective, cardioprotective, and anti-tumoral activities, among others). The primary goal of the present article is to review and clarify the common molecular mechanisms by which allicin and its derivates molecules may perform its therapeutic effects on cardiovascular diseases and neuroinflammatory processes. The intricate interface connecting the cardiovascular and nervous systems suggests that the impairment of one organ could contribute to the dysfunction of the other. Allicin might target the cornerstone of the pathological processes underlying cardiovascular and neuroinflammatory disorders, like inflammation, renin-angiotensin-aldosterone system (RAAS) hyperactivation, oxidative stress, and mitochondrial dysfunction. Indeed, the current evidence suggests that allicin improves mitochondrial function by enhancing the expression of HSP70 and NRF2, decreasing RAAS activation, and promoting mitochondrial fusion processes. Finally, allicin represents an attractive therapeutic alternative targeting the complex interaction between cardiovascular and neuroinflammatory disorders. [Display omitted]</description><subject>Allicin</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Cardiotonic Agents - therapeutic use</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cardiovascular disorders</subject><subject>Garlic</subject><subject>Humans</subject><subject>Inflammation - drug therapy</subject><subject>Mitochondria</subject><subject>Nervous System Diseases - drug therapy</subject><subject>Neuroprotection</subject><subject>Neuroprotective Agents - therapeutic use</subject><subject>Organosulfur compounds</subject><subject>Oxidative stress</subject><subject>Sulfinic Acids - therapeutic use</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kE1v1DAQhi1ERZfCD-CCcuSSZWzHSRZO1YoCUiUu5Wx5J-OtV_5Y7KRS_z2uUnrkNBrpeV_NPIx94LDlwPvPp623ZStA1J0PistXbMPHYddCL_lrtgEQXSsFqEv2tpQTACg1yDfsUgreKQnDhh2vvXfoYnO-NzkYTD4dH780-xRCik1InnDxJjeB8N5EV0JpzNG4WOYm0pKTi9abEMzsKm7i1KDJk0sPpqy5yRUyhco7dmGNL_T-eV6x3zff7vY_2ttf33_ur29blErOLYKwRFiP60mozh64Ai4HBQNye7DT1PckYdcpsgPspLEo-IgHOfY0yrFDecU-rb3nnP4sVGYdXEHy3kRKS9FCDp3sqq2xonxFMadSMll9zi6Y_Kg56Ce_-qSrX_3kV69-a-bjc_1yCDS9JP4JrcDXFaD65IOjrAs6ikiTy4SznpL7T_1fnRaM_Q</recordid><startdate>20200515</startdate><enddate>20200515</enddate><creator>Mocayar Marón, Feres José</creator><creator>Camargo, Alejandra Beatriz</creator><creator>Manucha, Walter</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200515</creationdate><title>Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases</title><author>Mocayar Marón, Feres José ; Camargo, Alejandra Beatriz ; Manucha, Walter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-c02feec4536e254fb150137507c1fbfdd66e30945ef7093afc218cb386e8384c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Allicin</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Cardiotonic Agents - therapeutic use</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cardiovascular disorders</topic><topic>Garlic</topic><topic>Humans</topic><topic>Inflammation - drug therapy</topic><topic>Mitochondria</topic><topic>Nervous System Diseases - drug therapy</topic><topic>Neuroprotection</topic><topic>Neuroprotective Agents - therapeutic use</topic><topic>Organosulfur compounds</topic><topic>Oxidative stress</topic><topic>Sulfinic Acids - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mocayar Marón, Feres José</creatorcontrib><creatorcontrib>Camargo, Alejandra Beatriz</creatorcontrib><creatorcontrib>Manucha, Walter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mocayar Marón, Feres José</au><au>Camargo, Alejandra Beatriz</au><au>Manucha, Walter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2020-05-15</date><risdate>2020</risdate><volume>249</volume><spage>117513</spage><epage>117513</epage><pages>117513-117513</pages><artnum>117513</artnum><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>According to investigations in phytomedicine and ethnopharmacology, the therapeutic properties of garlic (Allium sativum) have been described by ancestral cultures. Notwithstanding, it is of particular concern to elucidate the molecular mechanisms underlying this millenary empirical knowledge. Allicin (S-allyl prop-2-ene-1-sulfinothioate), a thioester of sulfenic acid, is one of the main bioactive compounds present in garlic, and it is responsible for the particular aroma of the spice. The pharmacological attributes of allicin integrate a broad spectrum of properties (e.g., anti-inflammatory, immunomodulatory, antibiotic, antifungal, antiparasitic, antioxidant, nephroprotective, neuroprotective, cardioprotective, and anti-tumoral activities, among others). The primary goal of the present article is to review and clarify the common molecular mechanisms by which allicin and its derivates molecules may perform its therapeutic effects on cardiovascular diseases and neuroinflammatory processes. The intricate interface connecting the cardiovascular and nervous systems suggests that the impairment of one organ could contribute to the dysfunction of the other. Allicin might target the cornerstone of the pathological processes underlying cardiovascular and neuroinflammatory disorders, like inflammation, renin-angiotensin-aldosterone system (RAAS) hyperactivation, oxidative stress, and mitochondrial dysfunction. Indeed, the current evidence suggests that allicin improves mitochondrial function by enhancing the expression of HSP70 and NRF2, decreasing RAAS activation, and promoting mitochondrial fusion processes. Finally, allicin represents an attractive therapeutic alternative targeting the complex interaction between cardiovascular and neuroinflammatory disorders. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>32145307</pmid><doi>10.1016/j.lfs.2020.117513</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2020-05, Vol.249, p.117513-117513, Article 117513
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_2374341178
source ScienceDirect Freedom Collection
subjects Allicin
Anti-Inflammatory Agents - therapeutic use
Cardiotonic Agents - therapeutic use
Cardiovascular Diseases - drug therapy
Cardiovascular disorders
Garlic
Humans
Inflammation - drug therapy
Mitochondria
Nervous System Diseases - drug therapy
Neuroprotection
Neuroprotective Agents - therapeutic use
Organosulfur compounds
Oxidative stress
Sulfinic Acids - therapeutic use
title Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A10%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Allicin%20pharmacology:%20Common%20molecular%20mechanisms%20against%20neuroinflammation%20and%20cardiovascular%20diseases&rft.jtitle=Life%20sciences%20(1973)&rft.au=Mocayar%20Mar%C3%B3n,%20Feres%20Jos%C3%A9&rft.date=2020-05-15&rft.volume=249&rft.spage=117513&rft.epage=117513&rft.pages=117513-117513&rft.artnum=117513&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2020.117513&rft_dat=%3Cproquest_cross%3E2374341178%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-c02feec4536e254fb150137507c1fbfdd66e30945ef7093afc218cb386e8384c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2374341178&rft_id=info:pmid/32145307&rfr_iscdi=true